The effect of probucol on intimal thickening of autologous vein grafts in hyperlipidemic rabbit

Vascular

Volumn 5, Issue 5, 1997, Pages 497-503

  Itoh, H ^a   Komori, K ^a   Okazaki, J ^a   Mawatari, K ^a   Kawasaki, K ^a   Kuma, S ^a   Eguchi, D ^a   Sugimachi, K ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

hemodynamics; hyperlipidemia; probucol; vein graft

Indexed keywords

PROBUCOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROMA; DRUG EFFECT; FEMORAL VEIN; GRAFT OCCLUSION; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; VEIN GRAFT;

ANIMALS; ANTICHOLESTEREMIC AGENTS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; FEMORAL VEIN; GRAFT OCCLUSION, VASCULAR; HINDLIMB; HYPERLIPIDEMIAS; MACROPHAGES; MALE; PROBUCOL; RABBITS; TRANSPLANTATION, AUTOLOGOUS; TUNICA INTIMA;

EID: 0031260178     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.1177/096721099700500513     Document Type: Article

References (34)

1. Leather R. P., Shah D. M., In situ vein arterial bypass. In Vascular Surgery, 3rd edn, ed. Rutherford R.B. W.B. Saunders, Philadelphia, USA, 1989, pp. 414–424.
2. Cambria R. P., Abbott W. M., Translocated autogenous vein grafts. In Vascular Surgery, 3rd edn, ed. Rutherford R.B. W.B. Saunders, Philadelphia, USA, 1989, pp. 425–433.
3. Chervu A., Moore W. S., An overview of intimal hyperplasia. Surgery, Gynecology and Obstetetrics, 1990, 171, 433–442.
4. Ross R., The pathogenesis of atherosclerosis: A perspective for 1990s. Nature, 1993, 362, 801–809.
5. Rosenfeld M. E., Tsukada T., Gown A. M., Ross R., Fatty streak initiation in Watanabe Heritable Hyperlipidemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis, 1987, 7, 9–23.
6. Rosenfeld M. E., Ross R., Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis, 1990, 10, 680–687.
7. Tsukada T., Rosenfeld R., Ross R., Gown A. M., Immunocytochemical analysis of cellular components in atherosclerotic lesions: Use of monoclonal antibodies with the Watanabe and fat-fed rabbit. Arteriosclerosis, 1985, 6, 601–613.
8. Stary H. C., Chandler A. B., Glagov S., et al, A definition of initial, fatty streak, and intermediate lesions of atherosclerosis: A report from the Committee on Vascular Lesions of the Council on Atherosclerosis. American Heart Association. Circulation, 1994, 89, 2462–2478.
9. Campeau L., Enjalbert M., Lesperance J., et al, The relation of risk factors to the development of atherosclerosis in the saphenous vein bypass grafts and the progression of disease in the native circulation: A study 10 years after aortocoronary bypass surgery. New England Journal of Medicine, 1984, 311, 1329–1332.
10. Amano J., Suzuki A., Sunamori M., Tsukada T., Numano F., Cytokinetic study of aortocoronary bypass vein grafts in place for less than six months. American Journal of Cardiology, 1991, 67, 1234–1236.
11. Tsukada T., Tejima T., Amano J., Suzuki A., Numano F., Immunocytochemical investigation of atherosclerotic changes observed in aortocoronary bypass vein grafts using monoclonal antibodies. Experimental Molecular Pathology, 1988, 48, 193–205.
12. Lytle B. W., Loop F. D., Cosgrove P. M., Ratliff N. B., Easley K., Taylor P. C., Long term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. Journal of Thoracic and Cardiovascular Surgery, 1985, 89, 248–258.
13. Walton K., Slaney W. G., Ashton F., Atherosclerosis in vascular grafts for peripheral vascular disease: Part 1. Autogenous vein grafts. Atherosclerosis, 1985, 54, 49–64.
14. Morinaga K., Okadome K., Kuroki M., Miyazaki T., Muto Y., Inokuchi K., Effect of wall shear stress on intimal thickening of arterially transplanted autogenous veins in dogs. Journal of Vascular Surgery, 1985, 2, 430–433.
15. Dobrin P. B., Litooy F. N., Endean E. D., Mechanical factors predisposing to intimal hyperplasia and medial thickening in autogenous vein grafts. Surgery, 1989, 105, 393–400.
16. Faulkner S. L., Fisher R. D., Conkle D. M., Page D. L., Bender H. W., Effect of blood flow rate on subendothelial proliferation in venous autografts used as arterial substitutes. Circulation (Suppl. 1), 1975, 51–52, 163–172.
17. Itoh H., Komori K., Onohara T., Funahashi S., Okadome K., Sugimachi K., Late graft failure of autologous vein grafts for arterial occlusive disease: Clinical and experimental studies. Surgery Today, 1995, 25, 293–298.
18. Itoh H., Komori K., Funahashi S., Okadome K., Sugimachi K., Initmal hyperplasia of autologous vein graft in hyperlipidemic rabbits with poor distal runoff. Atherosclerosis, 1994, 110, 259–270.
19. Carew T. E., Schwenke D. C., Steinberg D., Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: Evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proceedings of the National Academy of Sciences of the USA, 1987, 84, 7725–7729.
20. Kita T., Nagano Y., Yokode M., et al Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proceedings of the National Academy of Sciences of the USA, 1987, 84, 5928–5931.
21. Lusis A. J., Navab M., Lipoprotein oxidation and gene expression in the artery wall: New opportunities for pharmacologic intervention in atherosclerosis. Biochemical Pharmacology, 1993, 46, 2119–2126.
22. Shinomiya M., Shirai K., Saito Y., Yoshida S., Inhibition of intimathickening of carotid artery of rabbits and outgrowth of explants of aorta by probucol. Atherosclerosis, 1992, 97, 143–148.
23. King P., Royle J. P., Autogenous vein grafting in atheromatous rabbits. Cardiovascular Research, 1971, 6, 627–633.
24. McCann R. L., Larson R. M., Mitchener J. S., Fuchs J. C. A., Hagen P. O., Intimal thickening and hyperlipidemia in experimental primate vascular autografts. Annals of Surgery, 1979, 189, 62–67.
25. Numano F., Tsukada T., Amano J., Suzuki A., Experimental studies on vein graft atherosclerosis (I): Histological studies using monoclonal antibodies for smooth muscle cells and macrophages. Japanese Circulation Journal, 1990, 54, 1398–1406.
26. Ferns G. A. A., Forster L., Stewart-Lee A., Konneh M., Nourooz-Zadeh J., Anggard E. E., Probucol inhibits neointimal thickening and macrophage accumulation after balloon injury in the cholesterol-fed rabbit. Proceedings of the National Academy of Sciences of the USA, 1992, 89, 11312–11316.
27. Inokuchi K., Kusaba A., Kamori M., Kina M., Okadome K., Intraluminal velocity profiles analyzed from flow waveforms. Surgery, 1982, 92, 1006–1015.
28. Otsuka K., Takahara H., Okadome K., Sugimachi K., Computational simulation method of intraluminal velocity profile proved by laser doppler velocimeter. Journal of Surgical Research, 1990, 49, 408–412.
29. Parthasarathy S., Young S. G., Witztum J. L., Pittman R. C., Steinberg D., Probucol inhibits oxidative modification of low density lipoproteins. Journal of Clinical Investigation, 1986, 77, 641–644.
30. Matsuzawa Y., Yamashita S., Funahashi T., Yamamoto A., Tarui S., Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyper HDL2 cholesterolemia with abnormal cholesteryl ester transfer. American Journl of Cardiology, 1988, 62, 66B-72B.
31. Miettinen T. A., Huttunen J.K., Naukkarinen V., Strandberg T., Vanhanen H., Long-term use of probucol in the multifocal primary prevention of vascular disease. American Journal of Cardiology, 1986, 57, 49H-54H.
32. Kuo P. T., Wilson A.C., Kostis J.B., Moreyra A.E., Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery disease. American Joural of Cardiology, 1986, 57, 43H-48H.
33. Walldius G., Regnstorm J., Nilsson J., Johansson J., Schafer-Elinder L., Moelgaard J., Hadell K., Olsson A. G., Carlson L. A., The role of lipids and antioxidative factors for development of atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST). American Journal of Cardiology, 1993, 71, 15B-19B.
34. Yamamura S., Okadome K., Onohara T., Komori K., Sugimachi K., Blood flow and kinetics of smooth muscle cell proliferation in canine autogenous vein grafts: in vivo bromodeoxyuridine incorporation. Journal of Surgical Research, 1994, 56, 155–161.